[
 {
 "description": "Differentiation (NCM)",
"time_min": "1440",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "12",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (NCM) 24h",
"condid": "12_3" 
},
{
 "description": "Differentiation (PMA)",
"time_min": "30",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "15",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (PMA) vs Undifferentiated (Conditioned medium) 30min",
"condid": "15_3" 
},
{
 "description": "Differentiation (PMA)",
"time_min": "60",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "18",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (PMA) vs Undifferentiated (Conditioned medium) 1h",
"condid": "18_3" 
},
{
 "description": "Differentiation (PMA)",
"time_min": "360",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "21",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (PMA) vs Undifferentiated (Conditioned medium) 6h",
"condid": "21_3" 
},
{
 "description": "Differentiation (PMA)",
"time_min": "1440",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "24",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (PMA) vs Undifferentiated (Conditioned medium) 24h",
"condid": "24_3" 
},
{
 "description": "Differentiation (NCM)",
"time_min": "30",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "3",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (NCM) 30min",
"condid": "3_3" 
},
{
 "description": "Differentiation (NCM)",
"time_min": "60",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "6",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (NCM) 1h",
"condid": "6_3" 
},
{
 "description": "Differentiation (NCM)",
"time_min": "360",
"control_description": "Undifferentiated (Conditioned medium)",
"condition_id": "9",
"publication": "3",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "hESC (Odense-3 and HUES9)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "3",
"pub_id": "3",
"pubmed_id": "21406692",
"fauthor": "Rigbolt, KT",
"leading": "Blagoev, B",
"publication_date": "2011-03-16",
"journal": "Science signaling",
"title": "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.",
"pride": null,
"labels": "Differentiation (NCM) 6h",
"condid": "9_3" 
},
{
 "description": "Erlotinib",
"time_min": "0",
"control_description": "Untreated",
"condition_id": "96",
"publication": "30",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML KG-1",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "36",
"pub_id": "30",
"pubmed_id": "22115753",
"fauthor": "Weber, C",
"leading": "Daub, H",
"publication_date": "2012-01-17",
"journal": "Journal of proteomics",
"title": "Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells.",
"pride": null,
"labels": "Erlotinib",
"condid": "96_36" 
},
{
 "description": "Gefitinib",
"time_min": "0",
"control_description": "Untreated",
"condition_id": "99",
"publication": "30",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML KG-1",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "36",
"pub_id": "30",
"pubmed_id": "22115753",
"fauthor": "Weber, C",
"leading": "Daub, H",
"publication_date": "2012-01-17",
"journal": "Journal of proteomics",
"title": "Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells.",
"pride": null,
"labels": "Gefitinib",
"condid": "99_36" 
},
{
 "description": "BI 4834 (on Mitosis Nocodazole)",
"time_min": "15",
"control_description": "Mitosis (Nocodazole)",
"condition_id": "111",
"publication": "39",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "Methyl esterification",
"spectrometer": "LTQ-FT Ultra or LTQ Orbitrap XL",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "PepQuan (Bioworks)",
"experiment_id": "45",
"pub_id": "39",
"pubmed_id": "21857030",
"fauthor": "Grosstessner-Hain, K",
"leading": "Mechtler, K",
"publication_date": "2011-11-04",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Quantitative phospho-proteomics to investigate the polo-like kinase 1-dependent phospho-proteome.",
"pride": "PRD000226",
"labels": "BI 4834 (on Mitosis Nocodazole)",
"condid": "111_45" 
},
{
 "description": "Starved",
"time_min": null,
"control_description": "Insulin",
"condition_id": "114",
"publication": "42",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HEK-293",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "QSTAR Elite",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "Multiplierz",
"experiment_id": "48",
"pub_id": "42",
"pubmed_id": "21659604",
"fauthor": "Hsu, PP",
"leading": "Sabatini, DM",
"publication_date": "2011-06-10",
"journal": "Science (New York, N.Y.)",
"title": "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.",
"pride": null,
"labels": "Starved",
"condid": "114_48" 
},
{
 "description": "Torin1",
"time_min": null,
"control_description": "Insulin",
"condition_id": "117",
"publication": "42",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HEK-293",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "QSTAR Elite",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "Multiplierz",
"experiment_id": "48",
"pub_id": "42",
"pubmed_id": "21659604",
"fauthor": "Hsu, PP",
"leading": "Sabatini, DM",
"publication_date": "2011-06-10",
"journal": "Science (New York, N.Y.)",
"title": "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.",
"pride": null,
"labels": "Torin1",
"condid": "117_48" 
},
{
 "description": "Rapamycin",
"time_min": null,
"control_description": "Insulin",
"condition_id": "120",
"publication": "42",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HEK-293",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "QSTAR Elite",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "Multiplierz",
"experiment_id": "48",
"pub_id": "42",
"pubmed_id": "21659604",
"fauthor": "Hsu, PP",
"leading": "Sabatini, DM",
"publication_date": "2011-06-10",
"journal": "Science (New York, N.Y.)",
"title": "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.",
"pride": null,
"labels": "Rapamycin",
"condid": "120_48" 
},
{
 "description": "TSC2+/+ + Torin1",
"time_min": null,
"control_description": "Vehicle",
"condition_id": "123",
"publication": "42",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MEF",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "QSTAR Elite",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "Multiplierz",
"experiment_id": "51",
"pub_id": "42",
"pubmed_id": "21659604",
"fauthor": "Hsu, PP",
"leading": "Sabatini, DM",
"publication_date": "2011-06-10",
"journal": "Science (New York, N.Y.)",
"title": "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.",
"pride": null,
"labels": "TSC2+/+ + Torin1",
"condid": "123_51" 
},
{
 "description": "TSC2-/-",
"time_min": null,
"control_description": "Vehicle",
"condition_id": "126",
"publication": "42",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MEF",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "QSTAR Elite",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "Multiplierz",
"experiment_id": "51",
"pub_id": "42",
"pubmed_id": "21659604",
"fauthor": "Hsu, PP",
"leading": "Sabatini, DM",
"publication_date": "2011-06-10",
"journal": "Science (New York, N.Y.)",
"title": "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.",
"pride": null,
"labels": "TSC2-/-",
"condid": "126_51" 
},
{
 "description": "TSC2-/- + Torin1",
"time_min": null,
"control_description": "Vehicle",
"condition_id": "129",
"publication": "42",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MEF",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "QSTAR Elite",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "Multiplierz",
"experiment_id": "51",
"pub_id": "42",
"pubmed_id": "21659604",
"fauthor": "Hsu, PP",
"leading": "Sabatini, DM",
"publication_date": "2011-06-10",
"journal": "Science (New York, N.Y.)",
"title": "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.",
"pride": null,
"labels": "TSC2-/- + Torin1",
"condid": "129_51" 
},
{
 "description": "Crizotinib",
"time_min": null,
"control_description": "Untreated",
"condition_id": "186",
"publication": "48",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "NSCLC",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "57",
"pub_id": "48",
"pubmed_id": "23898821",
"fauthor": "Oppermann, FS",
"leading": "Daub, H",
"publication_date": "2013-09-06",
"journal": "Journal of proteome research",
"title": "Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.",
"pride": null,
"labels": "Crizotinib",
"condid": "186_57" 
},
{
 "description": "Untreated",
"time_min": null,
"control_description": "Untreated",
"condition_id": "189",
"publication": "48",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "NSCLC",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "57",
"pub_id": "48",
"pubmed_id": "23898821",
"fauthor": "Oppermann, FS",
"leading": "Daub, H",
"publication_date": "2013-09-06",
"journal": "Journal of proteome research",
"title": "Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.",
"pride": null,
"labels": "Untreated vs Untreated",
"condid": "189_57" 
},
{
 "description": "Untreated",
"time_min": null,
"control_description": "Crizotinib",
"condition_id": "192",
"publication": "48",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "NSCLC",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "57",
"pub_id": "48",
"pubmed_id": "23898821",
"fauthor": "Oppermann, FS",
"leading": "Daub, H",
"publication_date": "2013-09-06",
"journal": "Journal of proteome research",
"title": "Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.",
"pride": null,
"labels": "Untreated vs Crizotinib",
"condid": "192_57" 
},
{
 "description": "Crizotinib",
"time_min": null,
"control_description": "Untreated",
"condition_id": "186",
"publication": "48",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "NSCLC",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "mTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "60",
"pub_id": "48",
"pubmed_id": "23898821",
"fauthor": "Oppermann, FS",
"leading": "Daub, H",
"publication_date": "2013-09-06",
"journal": "Journal of proteome research",
"title": "Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.",
"pride": null,
"labels": "Crizotinib",
"condid": "186_60" 
},
{
 "description": "Untreated",
"time_min": null,
"control_description": "Untreated",
"condition_id": "189",
"publication": "48",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "NSCLC",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "mTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "60",
"pub_id": "48",
"pubmed_id": "23898821",
"fauthor": "Oppermann, FS",
"leading": "Daub, H",
"publication_date": "2013-09-06",
"journal": "Journal of proteome research",
"title": "Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.",
"pride": null,
"labels": "Untreated vs Untreated",
"condid": "189_60" 
},
{
 "description": "Untreated",
"time_min": null,
"control_description": "Crizotinib",
"condition_id": "192",
"publication": "48",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "NSCLC",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "mTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "60",
"pub_id": "48",
"pubmed_id": "23898821",
"fauthor": "Oppermann, FS",
"leading": "Daub, H",
"publication_date": "2013-09-06",
"journal": "Journal of proteome research",
"title": "Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.",
"pride": null,
"labels": "Untreated vs Crizotinib",
"condid": "192_60" 
},
{
 "description": "EGF",
"time_min": "15",
"control_description": "Untreated",
"condition_id": "240",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "63",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "EGF 15min",
"condid": "240_63" 
},
{
 "description": "EGF + SB202190",
"time_min": "15",
"control_description": "Untreated",
"condition_id": "243",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "63",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "EGF + SB202190 vs Untreated",
"condid": "243_63" 
},
{
 "description": "EGF + SB202190",
"time_min": "15",
"control_description": "EGF",
"condition_id": "246",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "63",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "EGF + SB202190 vs EGF",
"condid": "246_63" 
},
{
 "description": "EGF",
"time_min": "15",
"control_description": "Untreated",
"condition_id": "240",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "66",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "EGF 15min",
"condid": "240_66" 
},
{
 "description": "EGF + U0126",
"time_min": "15",
"control_description": "Untreated",
"condition_id": "252",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "66",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "EGF + U0126 vs Untreated",
"condid": "252_66" 
},
{
 "description": "EGF + U0126",
"time_min": "15",
"control_description": "EGF",
"condition_id": "255",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "66",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "EGF + U0126 vs EGF",
"condid": "255_66" 
},
{
 "description": "Mitosis (Nocodazole)",
"time_min": null,
"control_description": "Async cells",
"condition_id": "267",
"publication": "54",
"organism": "9606",
"scoring_method": "ASCORE",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Vista",
"experiment_id": "72",
"pub_id": "54",
"pubmed_id": "18669648",
"fauthor": "Dephoure, N",
"leading": "Gygi, SP",
"publication_date": "2008-08-06",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "A quantitative atlas of mitotic phosphorylation.",
"pride": null,
"labels": "Mitosis (Nocodazole)",
"condid": "267_72" 
},
{
 "description": "G1_S (Thymidine)",
"time_min": "0",
"control_description": "Async cells",
"condition_id": "72",
"publication": "54",
"organism": "9606",
"scoring_method": "ASCORE",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Vista",
"experiment_id": "72",
"pub_id": "54",
"pubmed_id": "18669648",
"fauthor": "Dephoure, N",
"leading": "Gygi, SP",
"publication_date": "2008-08-06",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "A quantitative atlas of mitotic phosphorylation.",
"pride": null,
"labels": "G1 S (Thymidine)",
"condid": "72_72" 
},
{
 "description": "Mitosis (Taxol)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "270",
"publication": "57",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Xpress",
"experiment_id": "75",
"pub_id": "57",
"pubmed_id": "21712546",
"fauthor": "Kettenbach, AN",
"leading": "Gerber, SA",
"publication_date": "2011-06-29",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.",
"pride": null,
"labels": "Mitosis (Taxol)",
"condid": "270_75" 
},
{
 "description": "Mitosis (MLN8054 0_25 microM)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "273",
"publication": "57",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Xpress",
"experiment_id": "75",
"pub_id": "57",
"pubmed_id": "21712546",
"fauthor": "Kettenbach, AN",
"leading": "Gerber, SA",
"publication_date": "2011-06-29",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.",
"pride": null,
"labels": "Mitosis (MLN8054 0 25 microM)",
"condid": "273_75" 
},
{
 "description": "Mitosis (MLN8054 1 microM)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "276",
"publication": "57",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Xpress",
"experiment_id": "75",
"pub_id": "57",
"pubmed_id": "21712546",
"fauthor": "Kettenbach, AN",
"leading": "Gerber, SA",
"publication_date": "2011-06-29",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.",
"pride": null,
"labels": "Mitosis (MLN8054 1 microM)",
"condid": "276_75" 
},
{
 "description": "Mitosis (MLN8054 5 microM)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "279",
"publication": "57",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Xpress",
"experiment_id": "75",
"pub_id": "57",
"pubmed_id": "21712546",
"fauthor": "Kettenbach, AN",
"leading": "Gerber, SA",
"publication_date": "2011-06-29",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.",
"pride": null,
"labels": "Mitosis (MLN8054 5 microM)",
"condid": "279_75" 
},
{
 "description": "Mitosis (AZD1152)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "282",
"publication": "57",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Xpress",
"experiment_id": "75",
"pub_id": "57",
"pubmed_id": "21712546",
"fauthor": "Kettenbach, AN",
"leading": "Gerber, SA",
"publication_date": "2011-06-29",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.",
"pride": null,
"labels": "Mitosis (AZD1152)",
"condid": "282_75" 
},
{
 "description": "Mitosis (BI2536)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "285",
"publication": "57",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Xpress",
"experiment_id": "75",
"pub_id": "57",
"pubmed_id": "21712546",
"fauthor": "Kettenbach, AN",
"leading": "Gerber, SA",
"publication_date": "2011-06-29",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.",
"pride": null,
"labels": "Mitosis (BI2536)",
"condid": "285_75" 
},
{
 "description": "Mitosis (short Taxol + BI2536)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "288",
"publication": "57",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Xpress",
"experiment_id": "75",
"pub_id": "57",
"pubmed_id": "21712546",
"fauthor": "Kettenbach, AN",
"leading": "Gerber, SA",
"publication_date": "2011-06-29",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.",
"pride": null,
"labels": "Mitosis (short Taxol + BI2536)",
"condid": "288_75" 
},
{
 "description": "EGF",
"time_min": "5",
"control_description": "Untreated",
"condition_id": "714",
"publication": "60",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "Xcalibur",
"quantification_software": "MaxQuant",
"experiment_id": "78",
"pub_id": "60",
"pubmed_id": "21955146",
"fauthor": "Engholm-Keller, K",
"leading": "Larsen, MR",
"publication_date": "2011-12-05",
"journal": "Journal of proteome research",
"title": "Multidimensional strategy for sensitive phosphoproteomics incorporating protein prefractionation combined with SIMAC, HILIC, and TiO(2) chromatography applied to proximal EGF signaling.",
"pride": null,
"labels": "EGF 5min",
"condid": "714_78" 
},
{
 "description": "Shigella infection",
"time_min": "15",
"control_description": "Uninfected",
"condition_id": "294",
"publication": "63",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Progenesis",
"quantification_software": "Progenesis",
"experiment_id": "81",
"pub_id": "63",
"pubmed_id": "23828894",
"fauthor": "Schmutz, C",
"leading": "Arrieumerlou, C",
"publication_date": "2013-10-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics.",
"pride": null,
"labels": "Shigella infection 15min",
"condid": "294_81" 
},
{
 "description": "Shigella infection",
"time_min": "30",
"control_description": "Uninfected",
"condition_id": "297",
"publication": "63",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Progenesis",
"quantification_software": "Progenesis",
"experiment_id": "81",
"pub_id": "63",
"pubmed_id": "23828894",
"fauthor": "Schmutz, C",
"leading": "Arrieumerlou, C",
"publication_date": "2013-10-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics.",
"pride": null,
"labels": "Shigella infection 30min",
"condid": "297_81" 
},
{
 "description": "Shigella infection",
"time_min": "60",
"control_description": "Uninfected",
"condition_id": "300",
"publication": "63",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Progenesis",
"quantification_software": "Progenesis",
"experiment_id": "81",
"pub_id": "63",
"pubmed_id": "23828894",
"fauthor": "Schmutz, C",
"leading": "Arrieumerlou, C",
"publication_date": "2013-10-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics.",
"pride": null,
"labels": "Shigella infection 1h",
"condid": "300_81" 
},
{
 "description": "Shigella infection",
"time_min": "120",
"control_description": "Uninfected",
"condition_id": "303",
"publication": "63",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Progenesis",
"quantification_software": "Progenesis",
"experiment_id": "81",
"pub_id": "63",
"pubmed_id": "23828894",
"fauthor": "Schmutz, C",
"leading": "Arrieumerlou, C",
"publication_date": "2013-10-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics.",
"pride": null,
"labels": "Shigella infection 3h",
"condid": "303_81" 
},
{
 "description": "anti-CD3",
"time_min": "0",
"control_description": "Time 0_5",
"condition_id": "318",
"publication": "69",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "87",
"pub_id": "69",
"pubmed_id": "24204825",
"fauthor": "Salek, M",
"leading": "Acuto, O",
"publication_date": "2013-11-08",
"journal": "PloS one",
"title": "Quantitative Phosphoproteome Analysis Unveils LAT as a Modulator of CD3ζ and ZAP-70 Tyrosine Phosphorylation.",
"pride": "PXD000341",
"labels": "anti-CD3 0min",
"condid": "318_87" 
},
{
 "description": "anti-CD3",
"time_min": "5",
"control_description": "Time 0_5",
"condition_id": "321",
"publication": "69",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "87",
"pub_id": "69",
"pubmed_id": "24204825",
"fauthor": "Salek, M",
"leading": "Acuto, O",
"publication_date": "2013-11-08",
"journal": "PloS one",
"title": "Quantitative Phosphoproteome Analysis Unveils LAT as a Modulator of CD3ζ and ZAP-70 Tyrosine Phosphorylation.",
"pride": "PXD000341",
"labels": "anti-CD3 5min",
"condid": "321_87" 
},
{
 "description": "anti-CD3",
"time_min": "10",
"control_description": "Time 0_5",
"condition_id": "324",
"publication": "69",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "87",
"pub_id": "69",
"pubmed_id": "24204825",
"fauthor": "Salek, M",
"leading": "Acuto, O",
"publication_date": "2013-11-08",
"journal": "PloS one",
"title": "Quantitative Phosphoproteome Analysis Unveils LAT as a Modulator of CD3ζ and ZAP-70 Tyrosine Phosphorylation.",
"pride": "PXD000341",
"labels": "anti-CD3 10min",
"condid": "324_87" 
},
{
 "description": "anti-CD3",
"time_min": "20",
"control_description": "Time 0_5",
"condition_id": "327",
"publication": "69",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "87",
"pub_id": "69",
"pubmed_id": "24204825",
"fauthor": "Salek, M",
"leading": "Acuto, O",
"publication_date": "2013-11-08",
"journal": "PloS one",
"title": "Quantitative Phosphoproteome Analysis Unveils LAT as a Modulator of CD3ζ and ZAP-70 Tyrosine Phosphorylation.",
"pride": "PXD000341",
"labels": "anti-CD3 20min",
"condid": "327_87" 
},
{
 "description": "LRRK2-IN-1 (Endogenous LRRK2)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "363",
"publication": "78",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SH-SY5Y neuroblastoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "105",
"pub_id": "78",
"pubmed_id": "24117733",
"fauthor": "Luerman, GC",
"leading": "Hirst, WD",
"publication_date": "2013-11-11",
"journal": "Journal of neurochemistry",
"title": "Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1.",
"pride": null,
"labels": "LRRK2-IN-1 (Endogenous LRRK2)",
"condid": "363_105" 
},
{
 "description": "LRRK2-IN-1 (LRRK2 overexpression)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "366",
"publication": "78",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SH-SY5Y neuroblastoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "108",
"pub_id": "78",
"pubmed_id": "24117733",
"fauthor": "Luerman, GC",
"leading": "Hirst, WD",
"publication_date": "2013-11-11",
"journal": "Journal of neurochemistry",
"title": "Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1.",
"pride": null,
"labels": "LRRK2-IN-1 (LRRK2 overexpression)",
"condid": "366_108" 
},
{
 "description": "PLK1 Inhibitor (G2r - BI2536 - 30m)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "369",
"publication": "81",
"organism": "9606",
"scoring_method": null,
"biological_sample": "U2OS osteosarcoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "MsQuant",
"experiment_id": "111",
"pub_id": "81",
"pubmed_id": "23612710",
"fauthor": "Halim, VA",
"leading": "Medema, RH",
"publication_date": "2013-04-24",
"journal": "Science signaling",
"title": "Comparative phosphoproteomic analysis of checkpoint recovery identifies new regulators of the DNA damage response.",
"pride": "PXD000222",
"labels": "PLK1 Inhibitor (G2r - BI2536 - 30m)",
"condid": "369_111" 
},
{
 "description": "PLK1 Inhibitor (G2r - BI2536 - 120m)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "372",
"publication": "81",
"organism": "9606",
"scoring_method": null,
"biological_sample": "U2OS osteosarcoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "MsQuant",
"experiment_id": "111",
"pub_id": "81",
"pubmed_id": "23612710",
"fauthor": "Halim, VA",
"leading": "Medema, RH",
"publication_date": "2013-04-24",
"journal": "Science signaling",
"title": "Comparative phosphoproteomic analysis of checkpoint recovery identifies new regulators of the DNA damage response.",
"pride": "PXD000222",
"labels": "PLK1 Inhibitor (G2r - BI2536 - 3h)",
"condid": "372_111" 
},
{
 "description": "PLK1 Inhibitor (G2r - BI2536 - 240m)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "375",
"publication": "81",
"organism": "9606",
"scoring_method": null,
"biological_sample": "U2OS osteosarcoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": "MsQuant",
"experiment_id": "111",
"pub_id": "81",
"pubmed_id": "23612710",
"fauthor": "Halim, VA",
"leading": "Medema, RH",
"publication_date": "2013-04-24",
"journal": "Science signaling",
"title": "Comparative phosphoproteomic analysis of checkpoint recovery identifies new regulators of the DNA damage response.",
"pride": "PXD000222",
"labels": "PLK1 Inhibitor (G2r - BI2536 - 4h)",
"condid": "375_111" 
},
{
 "description": "RG7356",
"time_min": "30",
"control_description": "Vehicle",
"condition_id": "102",
"publication": "87",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MDA-MB-231 (Breast Cancer Cell Line)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "117",
"pub_id": "87",
"pubmed_id": "22777824",
"fauthor": "Weigand, S",
"leading": "Tebbe, A",
"publication_date": "2012-09-03",
"journal": "Cancer research",
"title": "Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.",
"pride": null,
"labels": "RG7356 30min",
"condid": "102_117" 
},
{
 "description": "RG7356",
"time_min": "90",
"control_description": "Vehicle",
"condition_id": "105",
"publication": "87",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MDA-MB-231 (Breast Cancer Cell Line)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "117",
"pub_id": "87",
"pubmed_id": "22777824",
"fauthor": "Weigand, S",
"leading": "Tebbe, A",
"publication_date": "2012-09-03",
"journal": "Cancer research",
"title": "Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.",
"pride": null,
"labels": "RG7356 1.5h",
"condid": "105_117" 
},
{
 "description": "RG7356",
"time_min": "270",
"control_description": "Vehicle",
"condition_id": "387",
"publication": "87",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MDA-MB-231 (Breast Cancer Cell Line)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "117",
"pub_id": "87",
"pubmed_id": "22777824",
"fauthor": "Weigand, S",
"leading": "Tebbe, A",
"publication_date": "2012-09-03",
"journal": "Cancer research",
"title": "Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.",
"pride": null,
"labels": "RG7356 4.5h",
"condid": "387_117" 
},
{
 "description": "DNA damage (Etoposide)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "390",
"publication": "90",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "U2OS osteosarcoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "120",
"pub_id": "90",
"pubmed_id": "22424773",
"fauthor": "Beli, P",
"leading": "Choudhary, C",
"publication_date": "2012-04-30",
"journal": "Molecular cell",
"title": "Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response.",
"pride": null,
"labels": "DNA damage (Etoposide)",
"condid": "390_120" 
},
{
 "description": "DNA damage (Ionizing radiation)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "399",
"publication": "90",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "U2OS osteosarcoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "129",
"pub_id": "90",
"pubmed_id": "22424773",
"fauthor": "Beli, P",
"leading": "Choudhary, C",
"publication_date": "2012-04-30",
"journal": "Molecular cell",
"title": "Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response.",
"pride": null,
"labels": "DNA damage (Ionizing radiation)",
"condid": "399_129" 
},
{
 "description": "Dasatinib (5 nM)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "402",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "CML K-562",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "132",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "Dasatinib (5 nM)",
"condid": "402_132" 
},
{
 "description": "Dasatinib (50 nM)",
"time_min": null,
"control_description": "Untreated",
"condition_id": "405",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "CML K-562",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "132",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "Dasatinib (50 nM) vs Untreated",
"condid": "405_132" 
},
{
 "description": "Dasatinib (50 nM)",
"time_min": null,
"control_description": "Dasatinib (5 nM)",
"condition_id": "408",
"publication": "51",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "CML K-562",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "132",
"pub_id": "51",
"pubmed_id": "19651622",
"fauthor": "Pan, C",
"leading": "Mann, M",
"publication_date": "2009-12-07",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.",
"pride": null,
"labels": "Dasatinib (50 nM) vs Dasatinib (5 nM)",
"condid": "408_132" 
},
{
 "description": "Salmonella infection (Nucleus)",
"time_min": "2",
"control_description": "Uninfected",
"condition_id": "132",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Nucleus) 2min",
"condid": "132_135" 
},
{
 "description": "Salmonella infection (Nucleus)",
"time_min": "5",
"control_description": "Uninfected",
"condition_id": "135",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Nucleus) 5min",
"condid": "135_135" 
},
{
 "description": "Salmonella infection (Nucleus)",
"time_min": "10",
"control_description": "Uninfected",
"condition_id": "138",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Nucleus) 10min",
"condid": "138_135" 
},
{
 "description": "Salmonella infection (Nucleus)",
"time_min": "20",
"control_description": "Uninfected",
"condition_id": "141",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Nucleus) 20min",
"condid": "141_135" 
},
{
 "description": "Salmonella infection + dSopB (Nucleus)",
"time_min": "5",
"control_description": "Uninfected",
"condition_id": "144",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection + dSopB (Nucleus) 5min",
"condid": "144_135" 
},
{
 "description": "Salmonella infection + dSopB (Nucleus)",
"time_min": "20",
"control_description": "Uninfected",
"condition_id": "147",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection + dSopB (Nucleus) 20min",
"condid": "147_135" 
},
{
 "description": "Salmonella infection (Membrane)",
"time_min": "2",
"control_description": "Uninfected",
"condition_id": "150",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Membrane) 2min",
"condid": "150_135" 
},
{
 "description": "Salmonella infection (Membrane)",
"time_min": "5",
"control_description": "Uninfected",
"condition_id": "153",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Membrane) 5min",
"condid": "153_135" 
},
{
 "description": "Salmonella infection (Membrane)",
"time_min": "10",
"control_description": "Uninfected",
"condition_id": "156",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Membrane) 10min",
"condid": "156_135" 
},
{
 "description": "Salmonella infection (Membrane)",
"time_min": "20",
"control_description": "Uninfected",
"condition_id": "159",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Membrane) 20min",
"condid": "159_135" 
},
{
 "description": "Salmonella infection + dSopB (Membrane)",
"time_min": "5",
"control_description": "Uninfected",
"condition_id": "162",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection + dSopB (Membrane) 5min",
"condid": "162_135" 
},
{
 "description": "Salmonella infection + dSopB (Membrane)",
"time_min": "20",
"control_description": "Uninfected",
"condition_id": "165",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection + dSopB (Membrane) 20min",
"condid": "165_135" 
},
{
 "description": "Salmonella infection (Cytoplasm)",
"time_min": "2",
"control_description": "Uninfected",
"condition_id": "168",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Cytoplasm) 2min",
"condid": "168_135" 
},
{
 "description": "Salmonella infection (Cytoplasm)",
"time_min": "5",
"control_description": "Uninfected",
"condition_id": "171",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Cytoplasm) 5min",
"condid": "171_135" 
},
{
 "description": "Salmonella infection (Cytoplasm)",
"time_min": "10",
"control_description": "Uninfected",
"condition_id": "174",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Cytoplasm) 10min",
"condid": "174_135" 
},
{
 "description": "Salmonella infection (Cytoplasm)",
"time_min": "20",
"control_description": "Uninfected",
"condition_id": "177",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection (Cytoplasm) 20min",
"condid": "177_135" 
},
{
 "description": "Salmonella infection + dSopB (Cytoplasm)",
"time_min": "5",
"control_description": "Uninfected",
"condition_id": "180",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection + dSopB (Cytoplasm) 5min",
"condid": "180_135" 
},
{
 "description": "Salmonella infection + dSopB (Cytoplasm)",
"time_min": "20",
"control_description": "Uninfected",
"condition_id": "183",
"publication": "93",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "135",
"pub_id": "93",
"pubmed_id": "21934108",
"fauthor": "Rogers, LD",
"leading": "Foster, LJ",
"publication_date": "2011-09-21",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events.",
"pride": "PRD000525",
"labels": "Salmonella infection + dSopB (Cytoplasm) 20min",
"condid": "183_135" 
},
{
 "description": "Mitosis (Nocodazole)",
"time_min": "30",
"control_description": "Async cells",
"condition_id": "66",
"publication": "96",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa S3",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "138",
"pub_id": "96",
"pubmed_id": "20068231",
"fauthor": "Olsen, JV",
"leading": "Mann, M",
"publication_date": "2010-01-13",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.",
"pride": null,
"labels": "Mitosis (Nocodazole)",
"condid": "66_138" 
},
{
 "description": "G1 (Nocodazole)",
"time_min": "180",
"control_description": "Async cells",
"condition_id": "69",
"publication": "96",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa S3",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "138",
"pub_id": "96",
"pubmed_id": "20068231",
"fauthor": "Olsen, JV",
"leading": "Mann, M",
"publication_date": "2010-01-13",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.",
"pride": null,
"labels": "G1 (Nocodazole)",
"condid": "69_138" 
},
{
 "description": "G1_S (Thymidine)",
"time_min": "0",
"control_description": "Async cells",
"condition_id": "72",
"publication": "96",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa S3",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "138",
"pub_id": "96",
"pubmed_id": "20068231",
"fauthor": "Olsen, JV",
"leading": "Mann, M",
"publication_date": "2010-01-13",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.",
"pride": null,
"labels": "G1 S (Thymidine)",
"condid": "72_138" 
},
{
 "description": "G1_S (Aphidicolin)",
"time_min": "0",
"control_description": "G1_S (Thymidine)",
"condition_id": "78",
"publication": "96",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa S3",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "138",
"pub_id": "96",
"pubmed_id": "20068231",
"fauthor": "Olsen, JV",
"leading": "Mann, M",
"publication_date": "2010-01-13",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.",
"pride": null,
"labels": "G1 S (Aphidicolin) vs G1 S (Thymidine)",
"condid": "78_138" 
},
{
 "description": "Early S (Thymidine)",
"time_min": "150",
"control_description": "Async cells",
"condition_id": "81",
"publication": "96",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa S3",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "138",
"pub_id": "96",
"pubmed_id": "20068231",
"fauthor": "Olsen, JV",
"leading": "Mann, M",
"publication_date": "2010-01-13",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.",
"pride": null,
"labels": "Early S (Thymidine)",
"condid": "81_138" 
},
{
 "description": "Late S (Thymidine)",
"time_min": "330",
"control_description": "Async cells",
"condition_id": "84",
"publication": "96",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa S3",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "138",
"pub_id": "96",
"pubmed_id": "20068231",
"fauthor": "Olsen, JV",
"leading": "Mann, M",
"publication_date": "2010-01-13",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.",
"pride": null,
"labels": "Late S (Thymidine)",
"condid": "84_138" 
},
{
 "description": "S_G2 (Thymidine)",
"time_min": "450",
"control_description": "Async cells",
"condition_id": "87",
"publication": "96",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa S3",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "138",
"pub_id": "96",
"pubmed_id": "20068231",
"fauthor": "Olsen, JV",
"leading": "Mann, M",
"publication_date": "2010-01-13",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.",
"pride": null,
"labels": "S G2 (Thymidine)",
"condid": "87_138" 
},
{
 "description": "VEGF",
"time_min": "10",
"control_description": "Untreated",
"condition_id": "411",
"publication": "99",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HUVEC",
"comments": "Immunoaffinity precipitations of the peptides using anti-pY,  anti-MAPK substrate, anti Akt substrate, anti-PKA substrate or anti-PKC substrate",
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Ascore",
"quantification_software": "Mojave",
"experiment_id": "141",
"pub_id": "99",
"pubmed_id": "23592840",
"fauthor": "Zhuang, G",
"leading": "Ferrara, N",
"publication_date": "2013-04-17",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.",
"pride": null,
"labels": "VEGF 10min",
"condid": "411_141" 
},
{
 "description": "VEGF",
"time_min": "20",
"control_description": "Untreated",
"condition_id": "414",
"publication": "99",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HUVEC",
"comments": "Immunoaffinity precipitations of the peptides using anti-pY,  anti-MAPK substrate, anti Akt substrate, anti-PKA substrate or anti-PKC substrate",
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Ascore",
"quantification_software": "Mojave",
"experiment_id": "141",
"pub_id": "99",
"pubmed_id": "23592840",
"fauthor": "Zhuang, G",
"leading": "Ferrara, N",
"publication_date": "2013-04-17",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.",
"pride": null,
"labels": "VEGF 20min",
"condid": "414_141" 
},
{
 "description": "VEGF",
"time_min": "30",
"control_description": "Untreated",
"condition_id": "417",
"publication": "99",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HUVEC",
"comments": "Immunoaffinity precipitations of the peptides using anti-pY,  anti-MAPK substrate, anti Akt substrate, anti-PKA substrate or anti-PKC substrate",
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Ascore",
"quantification_software": "Mojave",
"experiment_id": "141",
"pub_id": "99",
"pubmed_id": "23592840",
"fauthor": "Zhuang, G",
"leading": "Ferrara, N",
"publication_date": "2013-04-17",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.",
"pride": null,
"labels": "VEGF 30min",
"condid": "417_141" 
},
{
 "description": "VEGF",
"time_min": "60",
"control_description": "Untreated",
"condition_id": "420",
"publication": "99",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HUVEC",
"comments": "Immunoaffinity precipitations of the peptides using anti-pY,  anti-MAPK substrate, anti Akt substrate, anti-PKA substrate or anti-PKC substrate",
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Ascore",
"quantification_software": "Mojave",
"experiment_id": "141",
"pub_id": "99",
"pubmed_id": "23592840",
"fauthor": "Zhuang, G",
"leading": "Ferrara, N",
"publication_date": "2013-04-17",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.",
"pride": null,
"labels": "VEGF 1h",
"condid": "420_141" 
},
{
 "description": "Sorafinib",
"time_min": null,
"control_description": "Untreated",
"condition_id": "423",
"publication": "99",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HUVEC",
"comments": "Immunoaffinity precipitations of the peptides using anti-pY,  anti-MAPK substrate, anti Akt substrate, anti-PKA substrate or anti-PKC substrate",
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Ascore",
"quantification_software": "Mojave",
"experiment_id": "141",
"pub_id": "99",
"pubmed_id": "23592840",
"fauthor": "Zhuang, G",
"leading": "Ferrara, N",
"publication_date": "2013-04-17",
"journal": "Science signaling",
"title": "Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.",
"pride": null,
"labels": "Sorafinib",
"condid": "423_141" 
},
{
 "description": "EGF",
"time_min": "10",
"control_description": "Untreated",
"condition_id": "426",
"publication": "102",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "mTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "144",
"pub_id": "102",
"pubmed_id": "22210691",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2012-06-13",
"journal": "Molecular & cellular proteomics : MCP",
"title": "iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics.",
"pride": null,
"labels": "EGF 10min",
"condid": "426_144" 
},
{
 "description": "EGF",
"time_min": "1440",
"control_description": "Untreated",
"condition_id": "429",
"publication": "102",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "mTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "144",
"pub_id": "102",
"pubmed_id": "22210691",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2012-06-13",
"journal": "Molecular & cellular proteomics : MCP",
"title": "iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics.",
"pride": null,
"labels": "EGF 24h",
"condid": "429_144" 
},
{
 "description": "EGF",
"time_min": "10",
"control_description": "Untreated",
"condition_id": "426",
"publication": "102",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "153",
"pub_id": "102",
"pubmed_id": "22210691",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2012-06-13",
"journal": "Molecular & cellular proteomics : MCP",
"title": "iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics.",
"pride": null,
"labels": "EGF 10min",
"condid": "426_153" 
},
{
 "description": "EGF",
"time_min": "1440",
"control_description": "Untreated",
"condition_id": "429",
"publication": "102",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "153",
"pub_id": "102",
"pubmed_id": "22210691",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2012-06-13",
"journal": "Molecular & cellular proteomics : MCP",
"title": "iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics.",
"pride": null,
"labels": "EGF 24h",
"condid": "429_153" 
},
{
 "description": "Bortezomib",
"time_min": null,
"control_description": "Untreated",
"condition_id": "432",
"publication": "105",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Jurkat",
"comments": "3 rounds of serial enrichment",
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "156",
"pub_id": "105",
"pubmed_id": "23749302",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2013-06-28",
"journal": "Nature methods",
"title": "Integrated proteomic analysis of post-translational modifications by serial enrichment.",
"pride": null,
"labels": "Bortezomib",
"condid": "432_156" 
},
{
 "description": "Bortezomib",
"time_min": null,
"control_description": "Untreated",
"condition_id": "432",
"publication": "105",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Jurkat",
"comments": "2 rounds of serial enrichment",
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "159",
"pub_id": "105",
"pubmed_id": "23749302",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2013-06-28",
"journal": "Nature methods",
"title": "Integrated proteomic analysis of post-translational modifications by serial enrichment.",
"pride": null,
"labels": "Bortezomib",
"condid": "432_159" 
},
{
 "description": "Bortezomib",
"time_min": null,
"control_description": "Untreated",
"condition_id": "432",
"publication": "105",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Jurkat",
"comments": "1 round of enrichment",
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "162",
"pub_id": "105",
"pubmed_id": "23749302",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2013-06-28",
"journal": "Nature methods",
"title": "Integrated proteomic analysis of post-translational modifications by serial enrichment.",
"pride": null,
"labels": "Bortezomib",
"condid": "432_162" 
},
{
 "description": "nonTargeted_siRNA",
"time_min": null,
"control_description": "PINK1_siRNA",
"condition_id": "447",
"publication": "108",
"organism": "9606",
"scoring_method": "ASCORE",
"biological_sample": "HEK-293",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "ProLucid",
"quantification_software": "Census",
"experiment_id": "168",
"pub_id": "108",
"pubmed_id": "24626860",
"fauthor": "Qin, X",
"leading": "Liao, L",
"publication_date": "2014-03-14",
"journal": "Molecular bioSystems",
"title": "Quantitative phosphoproteomic profiling of PINK1-deficient cells identifies phosphorylation changes in nuclear proteins.",
"pride": null,
"labels": "nonTargeted siRNA",
"condid": "447_168" 
},
{
 "description": "PINK1_siRNA",
"time_min": null,
"control_description": "nonTargeted_siRNA",
"condition_id": "453",
"publication": "108",
"organism": "9606",
"scoring_method": "ASCORE",
"biological_sample": "HEK-293",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "ProLucid",
"quantification_software": "Census",
"experiment_id": "168",
"pub_id": "108",
"pubmed_id": "24626860",
"fauthor": "Qin, X",
"leading": "Liao, L",
"publication_date": "2014-03-14",
"journal": "Molecular bioSystems",
"title": "Quantitative phosphoproteomic profiling of PINK1-deficient cells identifies phosphorylation changes in nuclear proteins.",
"pride": null,
"labels": "PINK1 siRNA",
"condid": "453_168" 
},
{
 "description": "Iloprost (2 nM)",
"time_min": "0.16",
"control_description": "Vehicle",
"condition_id": "465",
"publication": "114",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Platelet-rich plasma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": null,
"experiment_id": "174",
"pub_id": "114",
"pubmed_id": "24324209",
"fauthor": "Beck, F",
"leading": "Zahedi, RP",
"publication_date": "2014-01-31",
"journal": "Blood",
"title": "Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.",
"pride": "PXD000242",
"labels": "Iloprost (2 nM) 0.16min",
"condid": "465_174" 
},
{
 "description": "Iloprost (2 nM)",
"time_min": "0.5",
"control_description": "Vehicle",
"condition_id": "468",
"publication": "114",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Platelet-rich plasma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": null,
"experiment_id": "174",
"pub_id": "114",
"pubmed_id": "24324209",
"fauthor": "Beck, F",
"leading": "Zahedi, RP",
"publication_date": "2014-01-31",
"journal": "Blood",
"title": "Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.",
"pride": "PXD000242",
"labels": "Iloprost (2 nM) 0.50min",
"condid": "468_174" 
},
{
 "description": "Iloprost (2 nM)",
"time_min": "1",
"control_description": "Vehicle",
"condition_id": "471",
"publication": "114",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Platelet-rich plasma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": null,
"experiment_id": "174",
"pub_id": "114",
"pubmed_id": "24324209",
"fauthor": "Beck, F",
"leading": "Zahedi, RP",
"publication_date": "2014-01-31",
"journal": "Blood",
"title": "Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.",
"pride": "PXD000242",
"labels": "Iloprost (2 nM) 1min",
"condid": "471_174" 
},
{
 "description": "Iloprost (5 nM)",
"time_min": "0.16",
"control_description": "Vehicle",
"condition_id": "474",
"publication": "114",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Platelet-rich plasma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": null,
"experiment_id": "177",
"pub_id": "114",
"pubmed_id": "24324209",
"fauthor": "Beck, F",
"leading": "Zahedi, RP",
"publication_date": "2014-01-31",
"journal": "Blood",
"title": "Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.",
"pride": "PXD000242",
"labels": "Iloprost (5 nM) 0.16min",
"condid": "474_177" 
},
{
 "description": "Iloprost (5 nM)",
"time_min": "0.5",
"control_description": "Vehicle",
"condition_id": "477",
"publication": "114",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Platelet-rich plasma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": null,
"experiment_id": "177",
"pub_id": "114",
"pubmed_id": "24324209",
"fauthor": "Beck, F",
"leading": "Zahedi, RP",
"publication_date": "2014-01-31",
"journal": "Blood",
"title": "Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.",
"pride": "PXD000242",
"labels": "Iloprost (5 nM) 0.50min",
"condid": "477_177" 
},
{
 "description": "Iloprost (5 nM)",
"time_min": "1",
"control_description": "Vehicle",
"condition_id": "480",
"publication": "114",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Platelet-rich plasma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Mascot",
"quantification_software": null,
"experiment_id": "177",
"pub_id": "114",
"pubmed_id": "24324209",
"fauthor": "Beck, F",
"leading": "Zahedi, RP",
"publication_date": "2014-01-31",
"journal": "Blood",
"title": "Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways.",
"pride": "PXD000242",
"labels": "Iloprost (5 nM) 1min",
"condid": "480_177" 
},
{
 "description": "Quizartinib",
"time_min": null,
"control_description": "AML cell lines",
"condition_id": "483",
"publication": "117",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML Bone Marrow aspirate",
"comments": "Training Set",
"labelling_type": "metabolic",
"labelling_method": "Super-SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "180",
"pub_id": "117",
"pubmed_id": "24247654",
"fauthor": "Schaab, C",
"leading": "Serve, H",
"publication_date": "2014-03-05",
"journal": "Leukemia",
"title": "Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib.",
"pride": null,
"labels": "Quizartinib",
"condid": "483_180" 
},
{
 "description": "Quizartinib",
"time_min": null,
"control_description": "AML cell lines",
"condition_id": "483",
"publication": "117",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML Bone Marrow aspirate",
"comments": "Validation set",
"labelling_type": "metabolic",
"labelling_method": "Super-SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "183",
"pub_id": "117",
"pubmed_id": "24247654",
"fauthor": "Schaab, C",
"leading": "Serve, H",
"publication_date": "2014-03-05",
"journal": "Leukemia",
"title": "Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib.",
"pride": null,
"labels": "Quizartinib",
"condid": "483_183" 
},
{
 "description": "Differentiation (Serum free medium)",
"time_min": "1440",
"control_description": "Control",
"condition_id": "549",
"publication": "120",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Dental Follicle Cells",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "186",
"pub_id": "120",
"pubmed_id": "24706070",
"fauthor": "Beck, HC",
"leading": "Morsczeck, C",
"publication_date": "2014-04-07",
"journal": "Neurochemical research",
"title": "A Site-Specific Phosphorylation of the Focal Adhesion Kinase Controls the Formation of Spheroid Cell Clusters.",
"pride": null,
"labels": "Differentiation (Serum free medium) 24h",
"condid": "549_186" 
},
{
 "description": "Differentiation (Serum free medium)",
"time_min": "2880",
"control_description": "Control",
"condition_id": "552",
"publication": "120",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Dental Follicle Cells",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "186",
"pub_id": "120",
"pubmed_id": "24706070",
"fauthor": "Beck, HC",
"leading": "Morsczeck, C",
"publication_date": "2014-04-07",
"journal": "Neurochemical research",
"title": "A Site-Specific Phosphorylation of the Focal Adhesion Kinase Controls the Formation of Spheroid Cell Clusters.",
"pride": null,
"labels": "Differentiation (Serum free medium) 48h",
"condid": "552_186" 
},
{
 "description": "Ischemia",
"time_min": "5",
"control_description": "Control",
"condition_id": "573",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Ovarian Carcinoma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "192",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 5min",
"condid": "573_192" 
},
{
 "description": "Ischemia",
"time_min": "30",
"control_description": "Control",
"condition_id": "576",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Ovarian Carcinoma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "192",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 30min",
"condid": "576_192" 
},
{
 "description": "Ischemia",
"time_min": "60",
"control_description": "Control",
"condition_id": "579",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Ovarian Carcinoma",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "192",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 1h",
"condid": "579_192" 
},
{
 "description": "Ischemia",
"time_min": "5",
"control_description": "Control",
"condition_id": "573",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Basal Breast Cancer Tumor (WHIM6)",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "195",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 5min",
"condid": "573_195" 
},
{
 "description": "Ischemia",
"time_min": "30",
"control_description": "Control",
"condition_id": "576",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Basal Breast Cancer Tumor (WHIM6)",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "195",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 30min",
"condid": "576_195" 
},
{
 "description": "Ischemia",
"time_min": "60",
"control_description": "Control",
"condition_id": "579",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Basal Breast Cancer Tumor (WHIM6)",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "195",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 1h",
"condid": "579_195" 
},
{
 "description": "Ischemia",
"time_min": "5",
"control_description": "Control",
"condition_id": "573",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Luminal Breast Cancer Tumor (WHIM20)",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "198",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 5min",
"condid": "573_198" 
},
{
 "description": "Ischemia",
"time_min": "30",
"control_description": "Control",
"condition_id": "576",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Luminal Breast Cancer Tumor (WHIM20)",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "198",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 30min",
"condid": "576_198" 
},
{
 "description": "Ischemia",
"time_min": "60",
"control_description": "Control",
"condition_id": "579",
"publication": "126",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Luminal Breast Cancer Tumor (WHIM20)",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "iTRAQ",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Spectrum Mill",
"quantification_software": "Spectrum Mill",
"experiment_id": "198",
"pub_id": "126",
"pubmed_id": "24719451",
"fauthor": "Mertins, P",
"leading": "Carr, SA",
"publication_date": "2014-04-10",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.",
"pride": null,
"labels": "Ischemia 1h",
"condid": "579_198" 
},
{
 "description": "PGE2",
"time_min": "0",
"control_description": "Control",
"condition_id": "582",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "201",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 0min",
"condid": "582_201" 
},
{
 "description": "PGE2",
"time_min": "10",
"control_description": "Control",
"condition_id": "585",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "201",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 10min",
"condid": "585_201" 
},
{
 "description": "PGE2",
"time_min": "20",
"control_description": "Control",
"condition_id": "588",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "201",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 20min",
"condid": "588_201" 
},
{
 "description": "PGE2",
"time_min": "30",
"control_description": "Control",
"condition_id": "591",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "201",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 30min",
"condid": "591_201" 
},
{
 "description": "PGE2",
"time_min": "5",
"control_description": "Control",
"condition_id": "594",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "201",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 5min",
"condid": "594_201" 
},
{
 "description": "PGE2",
"time_min": "60",
"control_description": "Control",
"condition_id": "597",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "201",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 1h",
"condid": "597_201" 
},
{
 "description": "PGE2",
"time_min": "0",
"control_description": "Control",
"condition_id": "582",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": "enrichment T4+IMAC ",
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "204",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 0min",
"condid": "582_204" 
},
{
 "description": "PGE2",
"time_min": "10",
"control_description": "Control",
"condition_id": "585",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": "enrichment T4+IMAC ",
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "204",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 10min",
"condid": "585_204" 
},
{
 "description": "PGE2",
"time_min": "20",
"control_description": "Control",
"condition_id": "588",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": "enrichment T4+IMAC ",
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "204",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 20min",
"condid": "588_204" 
},
{
 "description": "PGE2",
"time_min": "30",
"control_description": "Control",
"condition_id": "591",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": "enrichment T4+IMAC ",
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "204",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 30min",
"condid": "591_204" 
},
{
 "description": "PGE2",
"time_min": "5",
"control_description": "Control",
"condition_id": "594",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": "enrichment T4+IMAC ",
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "204",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 5min",
"condid": "594_204" 
},
{
 "description": "PGE2",
"time_min": "60",
"control_description": "Control",
"condition_id": "597",
"publication": "129",
"organism": "9606",
"scoring_method": null,
"biological_sample": "Jurkat",
"comments": "enrichment T4+IMAC ",
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "204",
"pub_id": "129",
"pubmed_id": "24850871",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-05-22",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Single step enrichment by Ti4+-IMAC and label free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.",
"pride": "PXD000293",
"labels": "PGE2 1h",
"condid": "597_204" 
},
{
 "description": "preOIS",
"time_min": null,
"control_description": "preOIS (sh-C/EBPbeta)",
"condition_id": "648",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "preOIS vs preOIS (sh-C/EBPbeta)",
"condid": "648_216" 
},
{
 "description": "preOIS",
"time_min": null,
"control_description": "preOIS (sh-C/EBPbeta)",
"condition_id": "651",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "preOIS vs preOIS (sh-C/EBPbeta)",
"condid": "651_216" 
},
{
 "description": "preOIS (sh-C/EBPbeta)",
"time_min": null,
"control_description": "cycling",
"condition_id": "654",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "preOIS (sh-C/EBPbeta)",
"condid": "654_216" 
},
{
 "description": "preOIS (sh-C/EBPbeta)",
"time_min": null,
"control_description": "cycling",
"condition_id": "657",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "preOIS (sh-C/EBPbeta)",
"condid": "657_216" 
},
{
 "description": "preOIS",
"time_min": null,
"control_description": "cycling",
"condition_id": "660",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "preOIS vs cycling",
"condid": "660_216" 
},
{
 "description": "preOIS",
"time_min": null,
"control_description": "cycling",
"condition_id": "663",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "preOIS vs cycling",
"condid": "663_216" 
},
{
 "description": "OIS",
"time_min": null,
"control_description": "OIS (sh-C/EBPbeta)",
"condition_id": "666",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "OIS vs OIS (sh-C/EBPbeta)",
"condid": "666_216" 
},
{
 "description": "OIS",
"time_min": null,
"control_description": "OIS (sh-C/EBPbeta)",
"condition_id": "669",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "OIS vs OIS (sh-C/EBPbeta)",
"condid": "669_216" 
},
{
 "description": "OIS (sh-C/EBPbeta)",
"time_min": null,
"control_description": "cycling",
"condition_id": "672",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "OIS (sh-C/EBPbeta)",
"condid": "672_216" 
},
{
 "description": "OIS (sh-C/EBPbeta)",
"time_min": null,
"control_description": "cycling",
"condition_id": "675",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "OIS (sh-C/EBPbeta)",
"condid": "675_216" 
},
{
 "description": "OIS",
"time_min": null,
"control_description": "cycling",
"condition_id": "678",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "OIS vs cycling",
"condid": "678_216" 
},
{
 "description": "OIS",
"time_min": null,
"control_description": "cycling",
"condition_id": "681",
"publication": "135",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Fibroblast (Tig3)",
"comments": "enrichment T4+IMAC and anti-Tyr antibodies",
"labelling_type": "chemical",
"labelling_method": "Multiplex peptide stable isotope dimethyl labeling",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "In-house",
"experiment_id": "216",
"pub_id": "135",
"pubmed_id": "24961811",
"fauthor": "de Graaf, EL",
"leading": "Heck, AJ",
"publication_date": "2014-06-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Phosphoproteome dynamics in onset and maintenance of Oncogene-Induced Senescence.",
"pride": "PXD001068",
"labels": "OIS vs cycling",
"condid": "681_216" 
},
{
 "description": "TGF-beta",
"time_min": "5",
"control_description": "Control",
"condition_id": "684",
"publication": "138",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Keratinocytes (HaCaT)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "219",
"pub_id": "138",
"pubmed_id": "25056879",
"fauthor": "J D'Souza, RC",
"leading": "Sharma, K",
"publication_date": "2014-07-24",
"journal": "Science signaling",
"title": "Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-?.",
"pride": "PXD000496",
"labels": "TGF-beta 5min",
"condid": "684_219" 
},
{
 "description": "TGF-beta",
"time_min": "10",
"control_description": "Control",
"condition_id": "687",
"publication": "138",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Keratinocytes (HaCaT)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "219",
"pub_id": "138",
"pubmed_id": "25056879",
"fauthor": "J D'Souza, RC",
"leading": "Sharma, K",
"publication_date": "2014-07-24",
"journal": "Science signaling",
"title": "Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-?.",
"pride": "PXD000496",
"labels": "TGF-beta 10min",
"condid": "687_219" 
},
{
 "description": "TGF-beta",
"time_min": "15",
"control_description": "Control",
"condition_id": "690",
"publication": "138",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Keratinocytes (HaCaT)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "219",
"pub_id": "138",
"pubmed_id": "25056879",
"fauthor": "J D'Souza, RC",
"leading": "Sharma, K",
"publication_date": "2014-07-24",
"journal": "Science signaling",
"title": "Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-?.",
"pride": "PXD000496",
"labels": "TGF-beta 15min",
"condid": "690_219" 
},
{
 "description": "TGF-beta",
"time_min": "20",
"control_description": "Control",
"condition_id": "693",
"publication": "138",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "Keratinocytes (HaCaT)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "219",
"pub_id": "138",
"pubmed_id": "25056879",
"fauthor": "J D'Souza, RC",
"leading": "Sharma, K",
"publication_date": "2014-07-24",
"journal": "Science signaling",
"title": "Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-?.",
"pride": "PXD000496",
"labels": "TGF-beta 20min",
"condid": "693_219" 
},
{
 "description": "ATR inhibitor (VE-821)",
"time_min": null,
"control_description": "Control",
"condition_id": "696",
"publication": "141",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "222",
"pub_id": "141",
"pubmed_id": "25003641",
"fauthor": "Salovská, B",
"leading": "Tich, A",
"publication_date": "2014-07-09",
"journal": "International journal of molecular sciences",
"title": "Radiosensitization of Human Leukemic HL-60 Cells by ATR Kinase Inhibitor (VE-821): Phosphoproteomic Analysis.",
"pride": null,
"labels": "ATR inhibitor (VE-821)",
"condid": "696_222" 
},
{
 "description": "PIK3CA activation (H1047R)",
"time_min": null,
"control_description": "Control",
"condition_id": "699",
"publication": "144",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF10A (Breast epithelia)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "Proteome Discover",
"experiment_id": "225",
"pub_id": "144",
"pubmed_id": "25247763",
"fauthor": "Wu, X",
"leading": "Pandey, A",
"publication_date": "2014-09-23",
"journal": "Nature communications",
"title": "Activation of diverse signalling pathways by oncogenic PIK3CA mutations.",
"pride": "PXD000599",
"labels": "PIK3CA activation (H1047R)",
"condid": "699_225" 
},
{
 "description": "PIK3CA activation (H1047R) + inhibitor",
"time_min": null,
"control_description": "Control",
"condition_id": "702",
"publication": "144",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF10A (Breast epithelia)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "Proteome Discover",
"experiment_id": "225",
"pub_id": "144",
"pubmed_id": "25247763",
"fauthor": "Wu, X",
"leading": "Pandey, A",
"publication_date": "2014-09-23",
"journal": "Nature communications",
"title": "Activation of diverse signalling pathways by oncogenic PIK3CA mutations.",
"pride": "PXD000599",
"labels": "PIK3CA activation (H1047R) + inhibitor",
"condid": "702_225" 
},
{
 "description": "PIK3CA activation (E545K)",
"time_min": null,
"control_description": "Control",
"condition_id": "705",
"publication": "144",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF10A (Breast epithelia)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "Proteome Discover",
"experiment_id": "225",
"pub_id": "144",
"pubmed_id": "25247763",
"fauthor": "Wu, X",
"leading": "Pandey, A",
"publication_date": "2014-09-23",
"journal": "Nature communications",
"title": "Activation of diverse signalling pathways by oncogenic PIK3CA mutations.",
"pride": "PXD000599",
"labels": "PIK3CA activation (E545K)",
"condid": "705_225" 
},
{
 "description": "KRAS (G12D)",
"time_min": null,
"control_description": "Wild type",
"condition_id": "1203",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G12D) vs Wild type",
"condid": "1203_245" 
},
{
 "description": "KRAS (G13D)",
"time_min": null,
"control_description": "Wild type",
"condition_id": "1204",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G13D) vs Wild type",
"condid": "1204_245" 
},
{
 "description": "KRAS (G13D)",
"time_min": null,
"control_description": "KRAS (G12D)",
"condition_id": "1205",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G13D) vs KRAS (G12D)",
"condid": "1205_245" 
},
{
 "description": "KRAS (G12V)",
"time_min": null,
"control_description": "Wild type",
"condition_id": "1206",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G12V)",
"condid": "1206_245" 
},
{
 "description": "KRAS (G12D)",
"time_min": null,
"control_description": "Wild type",
"condition_id": "1207",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G12D) vs Wild type",
"condid": "1207_245" 
},
{
 "description": "KRAS (G12D)",
"time_min": null,
"control_description": "KRAS (G12V)",
"condition_id": "1208",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G12D) vs KRAS (G12V)",
"condid": "1208_245" 
},
{
 "description": "KRAS (G12V)",
"time_min": null,
"control_description": "Wild type",
"condition_id": "1209",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G12V)",
"condid": "1209_245" 
},
{
 "description": "KRAS (G13D)",
"time_min": null,
"control_description": "Wild type",
"condition_id": "1210",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G13D) vs Wild type",
"condid": "1210_245" 
},
{
 "description": "KRAS (G13D)",
"time_min": null,
"control_description": "KRAS (G12V)",
"condition_id": "1211",
"publication": "149",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SW48",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "245",
"pub_id": "149",
"pubmed_id": "25599653",
"fauthor": "Hammond, DE",
"leading": "",
"publication_date": "2015-03-06",
"journal": "Journal of proteome research",
"title": "Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.",
"pride": null,
"labels": "KRAS (G13D) vs KRAS (G12V)",
"condid": "1211_245" 
},
{
 "description": "AKTi (Akt inhibitor VIII)",
"time_min": null,
"control_description": "Control",
"condition_id": "1288",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "AKTi (Akt inhibitor VIII)",
"condid": "1288_272" 
},
{
 "description": "AKTi (MK-2206)",
"time_min": null,
"control_description": "Control",
"condition_id": "1289",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "AKTi (MK-2206)",
"condid": "1289_272" 
},
{
 "description": "CAMK2i (KN-93)",
"time_min": null,
"control_description": "Control",
"condition_id": "1290",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "CAMK2i (KN-93)",
"condid": "1290_272" 
},
{
 "description": "CAMK2i (KN-62) ",
"time_min": null,
"control_description": "Control",
"condition_id": "1291",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "CAMK2i (KN-62) ",
"condid": "1291_272" 
},
{
 "description": "EGFRi (PD-168393)",
"time_min": null,
"control_description": "Control",
"condition_id": "1292",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "EGFRi (PD-168393)",
"condid": "1292_272" 
},
{
 "description": "EGFRi (PD-153035)",
"time_min": null,
"control_description": "Control",
"condition_id": "1293",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "EGFRi (PD-153035)",
"condid": "1293_272" 
},
{
 "description": "ERKi (ERK inhibitor)",
"time_min": null,
"control_description": "Control",
"condition_id": "1294",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "ERKi (ERK inhibitor)",
"condid": "1294_272" 
},
{
 "description": "ERKi (ERK inhibitor II)",
"time_min": null,
"control_description": "Control",
"condition_id": "1295",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "ERKi (ERK inhibitor II)",
"condid": "1295_272" 
},
{
 "description": "MEKi (GSK-1120212) ",
"time_min": null,
"control_description": "Control",
"condition_id": "1296",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "MEKi (GSK-1120212) ",
"condid": "1296_272" 
},
{
 "description": "MEKi (U0126) ",
"time_min": null,
"control_description": "Control",
"condition_id": "1297",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "MEKi (U0126) ",
"condid": "1297_272" 
},
{
 "description": "mTORi (KU-0063794) ",
"time_min": null,
"control_description": "Control",
"condition_id": "1298",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "mTORi (KU63794) ",
"condid": "1298_272" 
},
{
 "description": "mTORi (Torin-1)",
"time_min": null,
"control_description": "Control",
"condition_id": "1299",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "mTORi (Torin-1)",
"condid": "1299_272" 
},
{
 "description": "P70S6K1i (PF-4708671)",
"time_min": null,
"control_description": "Control",
"condition_id": "1300",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "P70S6K1i (PF-4708671)",
"condid": "1300_272" 
},
{
 "description": "P70S6K1i (DG2)",
"time_min": null,
"control_description": "Control",
"condition_id": "1301",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "P70S6K1i (DG2)",
"condid": "1301_272" 
},
{
 "description": "PI3Ki (GDC-0941)",
"time_min": null,
"control_description": "Control",
"condition_id": "1302",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "PI3Ki (GDC-0941)",
"condid": "1302_272" 
},
{
 "description": "PI3Ki (PI-103)",
"time_min": null,
"control_description": "Control",
"condition_id": "1303",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "PI3Ki (PI-103)",
"condid": "1303_272" 
},
{
 "description": "PKCi (Gö-6976)",
"time_min": null,
"control_description": "Control",
"condition_id": "1304",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "PKCi (Gö-6976)",
"condid": "1304_272" 
},
{
 "description": "PKCi (BIM-1)",
"time_min": null,
"control_description": "Control",
"condition_id": "1305",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "PKCi (BIM-1)",
"condid": "1305_272" 
},
{
 "description": "PP2Ai (Okadaic acid)",
"time_min": null,
"control_description": "Control",
"condition_id": "1306",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "PP2Ai (Okadaic acid)",
"condid": "1306_272" 
},
{
 "description": "PP2Ai (Cantharidic acid)",
"time_min": null,
"control_description": "Control",
"condition_id": "1307",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "PP2Ai (Cantharidic acid)",
"condid": "1307_272" 
},
{
 "description": "ROCKi (H-1152)",
"time_min": null,
"control_description": "Control",
"condition_id": "1308",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "ROCKi (H-1152)",
"condid": "1308_272" 
},
{
 "description": "ROCKi (Y-27632)",
"time_min": null,
"control_description": "Control",
"condition_id": "1309",
"publication": "167",
"organism": "9606",
"scoring_method": null,
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "free",
"labelling_method": null,
"spectrometer": "LTQ Orbitrap",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Pescal",
"quantification_software": null,
"experiment_id": "272",
"pub_id": "167",
"pubmed_id": "26060313",
"fauthor": "Wilkes, EH",
"leading": "",
"publication_date": "2015-06-24",
"journal": "Proceedings of the National Academy of Sciences of the United States of America",
"title": "Empirical inference of circuitry and plasticity in a kinase signaling network.",
"pride": null,
"labels": "ROCKi (Y-27632)",
"condid": "1309_272" 
},
{
 "description": "shPP6c (Taxol)",
"time_min": null,
"control_description": "Control",
"condition_id": "1314",
"publication": "169",
"organism": "9606",
"scoring_method": null,
"biological_sample": "HeLa",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "Methyl esterification",
"spectrometer": "Fusion Orbitrap Tribrid",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "MassCroQ",
"experiment_id": "274",
"pub_id": "169",
"pubmed_id": "26462736",
"fauthor": "Rusin, SF",
"leading": "",
"publication_date": "2015-10-14",
"journal": "Science signaling",
"title": "Quantitative phosphoproteomics reveals new roles for the protein phosphatase PP6 in mitotic cells.",
"pride": null,
"labels": "shPP6c (Taxol)",
"condid": "1314_274" 
},
{
 "description": "NGF (TrkA overexpression)",
"time_min": "120",
"control_description": "Control",
"condition_id": "1317",
"publication": "170",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "SH-SY5Y neuroblastoma cells",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "275",
"pub_id": "170",
"pubmed_id": "25921289",
"fauthor": "Emdal, KB",
"leading": "",
"publication_date": "2015-04-29",
"journal": "Science signaling",
"title": "Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation.",
"pride": null,
"labels": "NGF (TrkA overexpression) 3h",
"condid": "1317_275" 
},
{
 "description": "Selumetinib (AZD6244)",
"time_min": null,
"control_description": "Control",
"condition_id": "1320",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Selumetinib (AZD6244)",
"condid": "1320_277" 
},
{
 "description": "Selumetinib (AZD6244)",
"time_min": null,
"control_description": "Control",
"condition_id": "1321",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Selumetinib (AZD6244)",
"condid": "1321_277" 
},
{
 "description": "Selumetinib (AZD6244)",
"time_min": null,
"control_description": "Control",
"condition_id": "1322",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Selumetinib (AZD6244)",
"condid": "1322_277" 
},
{
 "description": "Vemurafenib (PLX4032)",
"time_min": null,
"control_description": "Control",
"condition_id": "1323",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Vemurafenib (PLX4032) vs Control",
"condid": "1323_277" 
},
{
 "description": "Vemurafenib (PLX4032)",
"time_min": null,
"control_description": "Control",
"condition_id": "1324",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Vemurafenib (PLX4032) vs Control",
"condid": "1324_277" 
},
{
 "description": "Vemurafenib (PLX4032)",
"time_min": null,
"control_description": "Control",
"condition_id": "1325",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Vemurafenib (PLX4032) vs Control",
"condid": "1325_277" 
},
{
 "description": "Vemurafenib (PLX4032)",
"time_min": null,
"control_description": "Selumetinib (AZD6244)",
"condition_id": "1326",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Vemurafenib (PLX4032) vs Selumetinib (AZD6244)",
"condid": "1326_277" 
},
{
 "description": "Vemurafenib (PLX4032)",
"time_min": null,
"control_description": "Selumetinib (AZD6244)",
"condition_id": "1327",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Vemurafenib (PLX4032) vs Selumetinib (AZD6244)",
"condid": "1327_277" 
},
{
 "description": "Vemurafenib (PLX4032)",
"time_min": null,
"control_description": "Selumetinib (AZD6244)",
"condition_id": "1328",
"publication": "172",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "WM239A",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Sequest",
"quantification_software": "Perseus",
"experiment_id": "277",
"pub_id": "172",
"pubmed_id": "25850435",
"fauthor": "Stuart, SA",
"leading": "",
"publication_date": "2015-06-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.",
"pride": null,
"labels": "Vemurafenib (PLX4032) vs Selumetinib (AZD6244)",
"condid": "1328_277" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "15",
"control_description": "Control",
"condition_id": "1329",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "JE6.1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "278",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 15min",
"condid": "1329_278" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "30",
"control_description": "Control",
"condition_id": "1330",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "JE6.1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "278",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 30min",
"condid": "1330_278" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "60",
"control_description": "Control",
"condition_id": "1331",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "JE6.1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "278",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 1h",
"condid": "1331_278" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "120",
"control_description": "Control",
"condition_id": "1332",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "JE6.1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "278",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 3h",
"condid": "1332_278" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "15",
"control_description": "Control",
"condition_id": "1329",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "Jgamma1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "279",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 15min",
"condid": "1329_279" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "30",
"control_description": "Control",
"condition_id": "1330",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "Jgamma1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "279",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 30min",
"condid": "1330_279" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "60",
"control_description": "Control",
"condition_id": "1331",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "Jgamma1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "279",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 1h",
"condid": "1331_279" 
},
{
 "description": "anti-CD3 + anti-CD28",
"time_min": "120",
"control_description": "Control",
"condition_id": "1332",
"publication": "173",
"organism": "9606",
"scoring_method": "Ascore",
"biological_sample": "Jgamma1",
"comments": null,
"labelling_type": "chemical",
"labelling_method": "TMT",
"spectrometer": "LTQ Orbitrap XL",
"enrichment_method": "TiO2_IMAC",
"antibody": null,
"identification_software": "EasierMgf",
"quantification_software": "EasierMgf",
"experiment_id": "279",
"pub_id": "173",
"pubmed_id": "26546556",
"fauthor": "Nguyen, TD",
"leading": "",
"publication_date": "2015-11-30",
"journal": "Journal of proteomics",
"title": "The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.",
"pride": null,
"labels": "anti-CD3 + anti-CD28 3h",
"condid": "1332_279" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1369",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs DMSO",
"condid": "1369_286" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "captopril",
"condition_id": "1370",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs captopril",
"condid": "1370_286" 
},
{
 "description": "captopril",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1371",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "captopril",
"condid": "1371_286" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1372",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs DMSO",
"condid": "1372_286" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "ambroxol",
"condition_id": "1373",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs ambroxol",
"condid": "1373_286" 
},
{
 "description": "ambroxol",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1374",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "ambroxol",
"condid": "1374_286" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1375",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs DMSO",
"condid": "1375_286" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "paclitaxel",
"condition_id": "1376",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs paclitaxel",
"condid": "1376_286" 
},
{
 "description": "paclitaxel",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1377",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "paclitaxel",
"condid": "1377_286" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1378",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs DMSO",
"condid": "1378_286" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "carmustine",
"condition_id": "1379",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs carmustine",
"condid": "1379_286" 
},
{
 "description": "carmustine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1380",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "carmustine",
"condid": "1380_286" 
},
{
 "description": "doxorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1383",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "doxorubicin",
"condid": "1383_286" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1384",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs DMSO",
"condid": "1384_286" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "daunorubicin",
"condition_id": "1385",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs daunorubicin",
"condid": "1385_286" 
},
{
 "description": "daunorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1386",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "daunorubicin",
"condid": "1386_286" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1387",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs DMSO",
"condid": "1387_286" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "dexverapamil",
"condition_id": "1388",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs dexverapamil",
"condid": "1388_286" 
},
{
 "description": "dexverapamil",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1389",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "dexverapamil",
"condid": "1389_286" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1390",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs DMSO",
"condid": "1390_286" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "mesalazine",
"condition_id": "1391",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs mesalazine",
"condid": "1391_286" 
},
{
 "description": "mesalazine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1392",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "mesalazine",
"condid": "1392_286" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1393",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs DMSO",
"condid": "1393_286" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "anisomycin",
"condition_id": "1394",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs anisomycin",
"condid": "1394_286" 
},
{
 "description": "anisomycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1395",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "anisomycin",
"condid": "1395_286" 
},
{
 "description": "digitoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1398",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digitoxigenin",
"condid": "1398_286" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1399",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs DMSO",
"condid": "1399_286" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "digoxigenin",
"condition_id": "1400",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs digoxigenin",
"condid": "1400_286" 
},
{
 "description": "digoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1401",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxigenin",
"condid": "1401_286" 
},
{
 "description": "digoxin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1404",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxin",
"condid": "1404_286" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1405",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs DMSO",
"condid": "1405_286" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "Lanatoside C",
"condition_id": "1406",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs Lanatoside C",
"condid": "1406_286" 
},
{
 "description": "Lanatoside C",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1407",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "Lanatoside C",
"condid": "1407_286" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1408",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs DMSO",
"condid": "1408_286" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "captopril",
"condition_id": "1409",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs captopril",
"condid": "1409_286" 
},
{
 "description": "captopril",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1410",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "captopril",
"condid": "1410_286" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1411",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs DMSO",
"condid": "1411_286" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "ambroxol",
"condition_id": "1412",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs ambroxol",
"condid": "1412_286" 
},
{
 "description": "ambroxol",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1413",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "ambroxol",
"condid": "1413_286" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1414",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs DMSO",
"condid": "1414_286" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "paclitaxel",
"condition_id": "1415",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs paclitaxel",
"condid": "1415_286" 
},
{
 "description": "paclitaxel",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1416",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "paclitaxel",
"condid": "1416_286" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1417",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs DMSO",
"condid": "1417_286" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "carmustine",
"condition_id": "1418",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs carmustine",
"condid": "1418_286" 
},
{
 "description": "carmustine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1419",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "carmustine",
"condid": "1419_286" 
},
{
 "description": "doxorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1422",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "doxorubicin",
"condid": "1422_286" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1423",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs DMSO",
"condid": "1423_286" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "daunorubicin",
"condition_id": "1424",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs daunorubicin",
"condid": "1424_286" 
},
{
 "description": "daunorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1425",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "daunorubicin",
"condid": "1425_286" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1426",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs DMSO",
"condid": "1426_286" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "dexverapamil",
"condition_id": "1427",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs dexverapamil",
"condid": "1427_286" 
},
{
 "description": "dexverapamil",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1428",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "dexverapamil",
"condid": "1428_286" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1429",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs DMSO",
"condid": "1429_286" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "mesalazine",
"condition_id": "1430",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs mesalazine",
"condid": "1430_286" 
},
{
 "description": "mesalazine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1431",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "mesalazine",
"condid": "1431_286" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1432",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs DMSO",
"condid": "1432_286" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "anisomycin",
"condition_id": "1433",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs anisomycin",
"condid": "1433_286" 
},
{
 "description": "anisomycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1434",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "anisomycin",
"condid": "1434_286" 
},
{
 "description": "digitoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1437",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digitoxigenin",
"condid": "1437_286" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1438",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs DMSO",
"condid": "1438_286" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "digoxigenin",
"condition_id": "1439",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs digoxigenin",
"condid": "1439_286" 
},
{
 "description": "digoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1440",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxigenin",
"condid": "1440_286" 
},
{
 "description": "digoxin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1443",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxin",
"condid": "1443_286" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1444",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs DMSO",
"condid": "1444_286" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "Lanatoside C",
"condition_id": "1445",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs Lanatoside C",
"condid": "1445_286" 
},
{
 "description": "Lanatoside C",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1446",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "AML HL-60",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "286",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "Lanatoside C",
"condid": "1446_286" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1447",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs DMSO",
"condid": "1447_287" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "captopril",
"condition_id": "1448",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs captopril",
"condid": "1448_287" 
},
{
 "description": "captopril",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1449",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "captopril",
"condid": "1449_287" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1450",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs DMSO",
"condid": "1450_287" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "ambroxol",
"condition_id": "1451",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs ambroxol",
"condid": "1451_287" 
},
{
 "description": "ambroxol",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1452",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "ambroxol",
"condid": "1452_287" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1453",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs DMSO",
"condid": "1453_287" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "paclitaxel",
"condition_id": "1454",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs paclitaxel",
"condid": "1454_287" 
},
{
 "description": "paclitaxel",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1455",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "paclitaxel",
"condid": "1455_287" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1456",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs DMSO",
"condid": "1456_287" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "carmustine",
"condition_id": "1457",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs carmustine",
"condid": "1457_287" 
},
{
 "description": "carmustine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1458",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "carmustine",
"condid": "1458_287" 
},
{
 "description": "doxorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1461",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "doxorubicin",
"condid": "1461_287" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1462",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs DMSO",
"condid": "1462_287" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "daunorubicin",
"condition_id": "1463",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs daunorubicin",
"condid": "1463_287" 
},
{
 "description": "daunorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1464",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "daunorubicin",
"condid": "1464_287" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1465",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs DMSO",
"condid": "1465_287" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "dexverapamil",
"condition_id": "1466",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs dexverapamil",
"condid": "1466_287" 
},
{
 "description": "dexverapamil",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1467",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "dexverapamil",
"condid": "1467_287" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1468",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs DMSO",
"condid": "1468_287" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "mesalazine",
"condition_id": "1469",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs mesalazine",
"condid": "1469_287" 
},
{
 "description": "mesalazine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1470",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "mesalazine",
"condid": "1470_287" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1471",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs DMSO",
"condid": "1471_287" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "anisomycin",
"condition_id": "1472",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs anisomycin",
"condid": "1472_287" 
},
{
 "description": "anisomycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1473",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "anisomycin",
"condid": "1473_287" 
},
{
 "description": "digitoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1476",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digitoxigenin",
"condid": "1476_287" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1477",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs DMSO",
"condid": "1477_287" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "digoxigenin",
"condition_id": "1478",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs digoxigenin",
"condid": "1478_287" 
},
{
 "description": "digoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1479",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxigenin",
"condid": "1479_287" 
},
{
 "description": "digoxin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1482",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxin",
"condid": "1482_287" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1483",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs DMSO",
"condid": "1483_287" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "Lanatoside C",
"condition_id": "1484",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs Lanatoside C",
"condid": "1484_287" 
},
{
 "description": "Lanatoside C",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1485",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "Lanatoside C",
"condid": "1485_287" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1486",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs DMSO",
"condid": "1486_287" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "captopril",
"condition_id": "1487",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs captopril",
"condid": "1487_287" 
},
{
 "description": "captopril",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1488",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "captopril",
"condid": "1488_287" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1489",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs DMSO",
"condid": "1489_287" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "ambroxol",
"condition_id": "1490",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs ambroxol",
"condid": "1490_287" 
},
{
 "description": "ambroxol",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1491",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "ambroxol",
"condid": "1491_287" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1492",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs DMSO",
"condid": "1492_287" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "paclitaxel",
"condition_id": "1493",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs paclitaxel",
"condid": "1493_287" 
},
{
 "description": "paclitaxel",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1494",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "paclitaxel",
"condid": "1494_287" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1495",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs DMSO",
"condid": "1495_287" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "carmustine",
"condition_id": "1496",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs carmustine",
"condid": "1496_287" 
},
{
 "description": "carmustine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1497",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "carmustine",
"condid": "1497_287" 
},
{
 "description": "doxorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1500",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "doxorubicin",
"condid": "1500_287" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1501",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs DMSO",
"condid": "1501_287" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "daunorubicin",
"condition_id": "1502",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs daunorubicin",
"condid": "1502_287" 
},
{
 "description": "daunorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1503",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "daunorubicin",
"condid": "1503_287" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1504",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs DMSO",
"condid": "1504_287" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "dexverapamil",
"condition_id": "1505",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs dexverapamil",
"condid": "1505_287" 
},
{
 "description": "dexverapamil",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1506",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "dexverapamil",
"condid": "1506_287" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1507",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs DMSO",
"condid": "1507_287" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "mesalazine",
"condition_id": "1508",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs mesalazine",
"condid": "1508_287" 
},
{
 "description": "mesalazine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1509",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "mesalazine",
"condid": "1509_287" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1510",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs DMSO",
"condid": "1510_287" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "anisomycin",
"condition_id": "1511",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs anisomycin",
"condid": "1511_287" 
},
{
 "description": "anisomycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1512",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "anisomycin",
"condid": "1512_287" 
},
{
 "description": "digitoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1515",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digitoxigenin",
"condid": "1515_287" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1516",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs DMSO",
"condid": "1516_287" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "digoxigenin",
"condition_id": "1517",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs digoxigenin",
"condid": "1517_287" 
},
{
 "description": "digoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1518",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxigenin",
"condid": "1518_287" 
},
{
 "description": "digoxin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1521",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxin",
"condid": "1521_287" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1522",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs DMSO",
"condid": "1522_287" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "Lanatoside C",
"condition_id": "1523",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs Lanatoside C",
"condid": "1523_287" 
},
{
 "description": "Lanatoside C",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1524",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "MCF7",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "287",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "Lanatoside C",
"condid": "1524_287" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1525",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs DMSO",
"condid": "1525_288" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "captopril",
"condition_id": "1526",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs captopril",
"condid": "1526_288" 
},
{
 "description": "captopril",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1527",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "captopril",
"condid": "1527_288" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1528",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs DMSO",
"condid": "1528_288" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "ambroxol",
"condition_id": "1529",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs ambroxol",
"condid": "1529_288" 
},
{
 "description": "ambroxol",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1530",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "ambroxol",
"condid": "1530_288" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1531",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs DMSO",
"condid": "1531_288" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "paclitaxel",
"condition_id": "1532",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs paclitaxel",
"condid": "1532_288" 
},
{
 "description": "paclitaxel",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1533",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "paclitaxel",
"condid": "1533_288" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1534",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs DMSO",
"condid": "1534_288" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "carmustine",
"condition_id": "1535",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs carmustine",
"condid": "1535_288" 
},
{
 "description": "carmustine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1536",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "carmustine",
"condid": "1536_288" 
},
{
 "description": "doxorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1539",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "doxorubicin",
"condid": "1539_288" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1540",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs DMSO",
"condid": "1540_288" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "daunorubicin",
"condition_id": "1541",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs daunorubicin",
"condid": "1541_288" 
},
{
 "description": "daunorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1542",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "daunorubicin",
"condid": "1542_288" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1543",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs DMSO",
"condid": "1543_288" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "dexverapamil",
"condition_id": "1544",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs dexverapamil",
"condid": "1544_288" 
},
{
 "description": "dexverapamil",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1545",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "dexverapamil",
"condid": "1545_288" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1546",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs DMSO",
"condid": "1546_288" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "mesalazine",
"condition_id": "1547",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs mesalazine",
"condid": "1547_288" 
},
{
 "description": "mesalazine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1548",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "mesalazine",
"condid": "1548_288" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1549",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs DMSO",
"condid": "1549_288" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "anisomycin",
"condition_id": "1550",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs anisomycin",
"condid": "1550_288" 
},
{
 "description": "anisomycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1551",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "anisomycin",
"condid": "1551_288" 
},
{
 "description": "digitoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1554",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digitoxigenin",
"condid": "1554_288" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1555",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs DMSO",
"condid": "1555_288" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "digoxigenin",
"condition_id": "1556",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs digoxigenin",
"condid": "1556_288" 
},
{
 "description": "digoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1557",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxigenin",
"condid": "1557_288" 
},
{
 "description": "digoxin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1560",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxin",
"condid": "1560_288" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1561",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs DMSO",
"condid": "1561_288" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "Lanatoside C",
"condition_id": "1562",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs Lanatoside C",
"condid": "1562_288" 
},
{
 "description": "Lanatoside C",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1563",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "Lanatoside C",
"condid": "1563_288" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1564",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs DMSO",
"condid": "1564_288" 
},
{
 "description": "fulvestrant",
"time_min": null,
"control_description": "captopril",
"condition_id": "1565",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "fulvestrant vs captopril",
"condid": "1565_288" 
},
{
 "description": "captopril",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1566",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "captopril",
"condid": "1566_288" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1567",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs DMSO",
"condid": "1567_288" 
},
{
 "description": "clindamycin",
"time_min": null,
"control_description": "ambroxol",
"condition_id": "1568",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "clindamycin vs ambroxol",
"condid": "1568_288" 
},
{
 "description": "ambroxol",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1569",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "ambroxol",
"condid": "1569_288" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1570",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs DMSO",
"condid": "1570_288" 
},
{
 "description": "chlortetracycline",
"time_min": null,
"control_description": "paclitaxel",
"condition_id": "1571",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlortetracycline vs paclitaxel",
"condid": "1571_288" 
},
{
 "description": "paclitaxel",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1572",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "paclitaxel",
"condid": "1572_288" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1573",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs DMSO",
"condid": "1573_288" 
},
{
 "description": "chlorzoxazone",
"time_min": null,
"control_description": "carmustine",
"condition_id": "1574",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "chlorzoxazone vs carmustine",
"condid": "1574_288" 
},
{
 "description": "carmustine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1575",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "carmustine",
"condid": "1575_288" 
},
{
 "description": "doxorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1578",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "doxorubicin",
"condid": "1578_288" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1579",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs DMSO",
"condid": "1579_288" 
},
{
 "description": "staurosporine",
"time_min": null,
"control_description": "daunorubicin",
"condition_id": "1580",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "staurosporine vs daunorubicin",
"condid": "1580_288" 
},
{
 "description": "daunorubicin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1581",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "daunorubicin",
"condid": "1581_288" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1582",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs DMSO",
"condid": "1582_288" 
},
{
 "description": "irinotecan",
"time_min": null,
"control_description": "dexverapamil",
"condition_id": "1583",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "irinotecan vs dexverapamil",
"condid": "1583_288" 
},
{
 "description": "dexverapamil",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1584",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "dexverapamil",
"condid": "1584_288" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1585",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs DMSO",
"condid": "1585_288" 
},
{
 "description": "scriptaid",
"time_min": null,
"control_description": "mesalazine",
"condition_id": "1586",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "scriptaid vs mesalazine",
"condid": "1586_288" 
},
{
 "description": "mesalazine",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1587",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "mesalazine",
"condid": "1587_288" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1588",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs DMSO",
"condid": "1588_288" 
},
{
 "description": "trichostatin A",
"time_min": null,
"control_description": "anisomycin",
"condition_id": "1589",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "trichostatin A vs anisomycin",
"condid": "1589_288" 
},
{
 "description": "anisomycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1590",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "anisomycin",
"condid": "1590_288" 
},
{
 "description": "digitoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1593",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digitoxigenin",
"condid": "1593_288" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1594",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs DMSO",
"condid": "1594_288" 
},
{
 "description": "valproic acid",
"time_min": null,
"control_description": "digoxigenin",
"condition_id": "1595",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "valproic acid vs digoxigenin",
"condid": "1595_288" 
},
{
 "description": "digoxigenin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1596",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxigenin",
"condid": "1596_288" 
},
{
 "description": "digoxin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1599",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "digoxin",
"condid": "1599_288" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1600",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs DMSO",
"condid": "1600_288" 
},
{
 "description": "geldanamycin",
"time_min": null,
"control_description": "Lanatoside C",
"condition_id": "1601",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "geldanamycin vs Lanatoside C",
"condid": "1601_288" 
},
{
 "description": "Lanatoside C",
"time_min": null,
"control_description": "DMSO",
"condition_id": "1602",
"publication": "174",
"organism": "9606",
"scoring_method": "Localization Probability",
"biological_sample": "PC-3 (Prostate Cancer)",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "Orbitrap (Q Exactive)",
"enrichment_method": "IMAC",
"antibody": null,
"identification_software": "MaxQuant",
"quantification_software": "MaxQuant",
"experiment_id": "288",
"pub_id": "174",
"pubmed_id": "26912667",
"fauthor": "Abelin, JG",
"leading": "",
"publication_date": "2016-02-25",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes.",
"pride": "",
"labels": "Lanatoside C",
"condid": "1602_288" 
},
{
 "description": "Differentiation (Serum)",
"time_min": null,
"control_description": "Control",
"condition_id": "1603",
"publication": "175",
"organism": "9606",
"scoring_method": null,
"biological_sample": "GB2",
"comments": null,
"labelling_type": "metabolic",
"labelling_method": "SILAC",
"spectrometer": "LTQ Orbitrap Velos",
"enrichment_method": "TiO2",
"antibody": null,
"identification_software": "Proteome Discover",
"quantification_software": "Proteome Discover",
"experiment_id": "289",
"pub_id": "175",
"pubmed_id": "26670566",
"fauthor": "Narushima, Y",
"leading": "",
"publication_date": "2016-03-02",
"journal": "Molecular & cellular proteomics : MCP",
"title": "Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties.",
"pride": "",
"labels": "Differentiation (Serum)",
"condid": "1603_289" 
} 
]
